BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
47 hedge funds and large institutions have $16.9M invested in Baudax Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $34.8M → $16.9M (-$17.9M)
Holders
47
Holding in Top 10
2
Calls
$2.13M
Puts
$37K
Top Buyers
| 1 | +$2.22M | |
| 2 | +$1.51M | |
| 3 | +$1.07M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$992K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$927K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$1.93M | |
| 3 | -$1.32M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$761K |
| 5 |
Renaissance Technologies
New York
|
-$663K |